Health Care › Biological Products (No Diagnostic Substances)

ADPT Price Correlated With Financials For Adaptive Biotechnologies

Free historical financial statements for Adaptive Biotechnologies Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 11 quarters since 2020. Compare with ADPT stock chart to see long term trends.

ADPT Stock Compared to Quarterly

log linear

ADPT Income Statement

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Net Income:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

ADPT Cash Flow

Operating Activities Net Income:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

ADPT Balance Sheet

Cash and Cash Equivalents:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Total Short-Term Liabilities:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Viking Global Investors Lp

29,993,708 sh

$213,555

Vanguard Group Inc

11,671,783 sh

95,409 sh
1%

$83,104

-$10,550

Matrix Capital Management Company, Lp

11,572,590 sh

$82,397

Blackrock Inc.

10,119,409 sh

1,098,301 sh
12%

$72,051

-$931

Ark Investment Management LLC

9,336,619 sh

563,601 sh
6%

$66,477

-$2,128

Nikko Asset Management Americas, Inc.

4,838,191 sh

219,792 sh
5%

$33,238

-$2,878

Sumitomo Mitsui Trust Holdings, Inc.

4,838,191 sh

219,792 sh
5%

$34,448

-$2,915

Blue Water Life Science Advisors, LLC

3,600,434 sh

480,000 sh
15%

$25,635

$391

Bellevue Group Ag

3,279,620 sh

-259,435 sh
-7%

$23,351

-$5,280

State Street Corp

2,476,435 sh

137,051 sh
6%

$17,632

-$1,294

Geode Capital Management, LLC

2,050,178 sh

19,793 sh
1%

$14,597

-$1,828

Goldman Sachs Group Inc

1,906,589 sh

566,107 sh
42%

$13,575

$2,730

Aristotle Atlantic Partners, LLC

1,894,395 sh

565,127 sh
43%

$13,488

$2,734

Price T Rowe Associates Inc /Md/

1,892,084 sh

-10,291,811 sh
-84%

$13,472

-$85,096

Federated Hermes, Inc.

1,401,339 sh

3,806 sh
0%

$9,978

-$1,328

Principal Financial Group Inc

1,314,279 sh

113,217 sh
9%

$9,358

-$359

Eagle Health Investments LP

1,214,860 sh

$8,650

Massachusetts Financial Services Co /Ma/

1,213,915 sh

370,839 sh
44%

$8,644

$1,824

Northern Trust Corp

1,165,834 sh

701,576 sh
151%

$8,301

$1,858

Morgan Stanley

1,021,461 sh

-125,905 sh
-11%

$7,274

-$2,008

Data imported from Adaptive Biotechnologies Corp SEC filings. Check original filings before making any investment decision.